The role of chronic disease in the costs of potentially preventable emergency department use during treatment: A regional study
| العنوان: | The role of chronic disease in the costs of potentially preventable emergency department use during treatment: A regional study |
|---|---|
| المؤلفون: | Sharon Chance, Thomas David Brown, Stuart Greenlee, Keith D. Eaton, Sarah Barger, Rose Guerrero, John Whitelaw Rieke, Catherine R. Fedorenko, Julia Rose Walker, Marilyn Moorhouse, Bruce Smith, Mary Gunkel, Ted Conklin, Renato G. Martins, Karma L. Kreizenbeck, Mikael Anne Greenwood-Hickman, Scott D. Ramsey, Laura Panattoni, Gary H. Lyman |
| المصدر: | Journal of Clinical Oncology. 35:6505-6505 |
| بيانات النشر: | American Society of Clinical Oncology (ASCO), 2017. |
| سنة النشر: | 2017 |
| مصطلحات موضوعية: | Cancer Research, business.industry, media_common.quotation_subject, Emergency department, medicine.disease, Chronic disease, Oncology, Medicine, Quality (business), Metric (unit), Medical emergency, business, Medicaid, media_common |
| الوصف: | 6505 Background: The Centers for Medicare and Medicaid Services (CMS) released a quality metric for potentially preventable chemotherapy-associated emergency department (ED) use, effective in 2020. This metric excludes diagnoses with emerging evidence for outpatient management, such as proactive symptom management (PSM) and those for ambulatory care sensitive chronic conditions. Little is known about the intersection between potentially preventable ED visits due to cancer vs. other chronic disease. This study characterized the number and costs of ED visits during treatment. Methods: Western Washington cancer registry records from 2011- 2015 were linked with claims from two commercial insurers. Patients with newly diagnosed solid tumors undergoing initial treatment with chemotherapy or radiation were eligible. ED use was tracked one year post treatment initiation. ED diagnosis codes for fields 1-10 from the CMS metric and the PSM literature were labeled “Potentially Preventable” (Pp). Codes from the Agency for Healthcare Research and Quality’s Prevention Quality Indicators (PQI) for Chronic Conditions were labeled “Potentially Preventable-Chronic Disease” (PpChronic). Costs were adjusted to $2016. Results: Of the 7,053 eligible patients, 2,543 (36.1%) visited the ED (median # visits [IQR]: 1 [1-2]). The most commonly listed codes included Pain (1,054 visits) and Dyspnea (279 visits) for Pp, Hypertension-PQI (652 visits) and COPD-PQI (206 visits) for PpChronic, and Diabetes (247 visits) and Hyperlipidemia (181 visits) for the other codes. Spending on ED visits including both potentially preventable cancer and chronic disease diagnoses totalled $706,552 (20% of ED costs). Conclusions: One fifth of ED costs potentially resulted from simultaneous poor cancer symptom and chronic disease management. Future research should explore the role of chronic illness in categorizing which ED visits are potentially preventable during cancer treatment. [Table: see text] |
| تدمد: | 1527-7755 0732-183X |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_________::2bd5052c9b4649ee784fea7e5a269c15 https://doi.org/10.1200/jco.2017.35.15_suppl.6505 |
| رقم الأكسشن: | edsair.doi...........2bd5052c9b4649ee784fea7e5a269c15 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 15277755 0732183X |
|---|